Title:

Moderna Spikevax Original/Omicron BA.4-5 and XBB.1.5 COVID-19 vaccines

Description:

This course provides specific information about the Moderna Spikevax branded COVID-19 vaccines for those aged 18 years and over. It is designed to provide healthcare workers with the knowledge they need to administer these vaccines safely and effectively to eligible individuals. The material covers the Spikevax Original/Omicron BA.4-5 (25/25 micrograms/dose) vaccine and the latest Spikevax XBB.1.5 vaccine which was approved by the MHRA on 15th September 2023 for administration during the autumn 2023 vaccination campaign. Collectively these will be referred to as the Spikevax vaccines.

The session will cover key information including how the vaccines work, how they should be stored, prepared and administered and any contraindications, precautions and potential vaccine reactions. The Core Knowledge session covers key areas including legal aspects of vaccination. The Core Knowledge session must therefore be completed in addition to this vaccine-specific session.

After completing this session about the Spikevax COVID-19 vaccines, you should complete the accompanying knowledge assessment.

These vaccines are recommended from age 18 years. If you are going to be vaccinating eligible individuals who have not yet attained 18 years of age you must complete the relevant Pfizer BioNTech vaccine-specific sessions.

It is important to note that the different types of COVID-19 vaccines have different storage, reconstitution and administration requirements. Vaccines produced by the same manufacturer, including those with similar brand names, may, too, have different requirements. You must be familiar with the specific recommendations for the COVID-19 vaccine you are delivering.

Hierarchy:

COVID-19 Vaccination > Moderna Spikevax Original/Omicron BA.4-5 and XBB.1.5 COVID-19 vaccines

Keywords:

COVID, 19, coronavirus, vaccine, vaccination, immuniser, immunisation, Moderna

Created:

9 Mar 2021

Updated:

5 Oct 2023